INVESTING TO
MAKE TREATMENTS
"CLINICAL TRIAL-READY"
The $725,000 research investment will prepare powerful natural killer cell immunotherapy to move into clinical trials.
Learn moreThis website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
The $725,000 research investment will prepare powerful natural killer cell immunotherapy to move into clinical trials.
Learn more
We are driving ovarian cancer research in Canada faster than ever – changing the landscape of available treatment options. After decades without real change, improved outcomes are finally possible.
Read our latest impact reportWomen deserve to live their lives freely, fully, and uninhibited by ovarian cancer.
Our mission is clear: to boldly and unapologetically take action against ovarian cancer until the number of deaths from this disease is zero.
– Tania Vrionis, CEO, Ovarian Cancer Canada
Take Action
Ovarian cancer isn’t just one disease, it’s many different types of cancer. Outcomes haven’t changed in 50 years, and we will not rest until women are able to live their lives freely, fully, and uninhibited by ovarian cancer.
Subscribe to our newsletter to learn about our research, community, and ways to get involved.